Autism Oxytocin Brain Project
Completed · Phase 2 · Has a placebo group
Conditions studied: Autism, Autism Spectrum Disorder
In brief
The main goal of the study is to look at the effects of intranasal oxytocin on the brain in Autism Spectrum Disorder (ASD). Oxytocin is a hormone that exists naturally in the body and the brain, affecting a wide range of social behaviors and emotions. The investigators will study the effects of different treatments (3 doses of oxytocin and one dose of placebo) on brain functional connectivity at rest in patients with ASD, using functional magnetic resonance imaging (fMRI). Investigators also seek to study how the effects of oxytocin treatment can be affected by genetic, immune and environmental factors.
Key facts
- Study ID
- NCT03033784
- Run by
- Emory University
- People needed
- 51
- Starts
- 2017-05-10
- Expected to finish
- 2018-10-03
- Last updated by the study team
- 2021-01-12
Who can join
Age: 18 and older, up to 45. Sex: male. Healthy volunteers: accepted.
Where it is running
- Emory University — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.